Pediatric News - Strattera now available
Strattera (atomoxetine), the first non-stimulant approved for the treatment of attention-deficit hyperactivity disorder is now available by prescription in pharmacies nationwide. Strattera also is approved for treating attention-deficit hyperactivity disorder in adults. For more information, contact Eli Lilly & Co. at 800-545-5979 or visit www.strattera.com.
Related Results
StratteraStrattera dispensingStrattera now availableApprovable letter for StratteraNew warning for Strattera
COPYRIGHT 2003 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning
